FDA approves 1st non-drug treatment for Restless Leg Syndrome

California-based Sensory Medical touts FDA clearance for its breakthrough Relaxis vibration therapy for treating restless leg syndrome.

FDA regulators this week cleared the 1st non-drug therapy for restless leg syndrome, Sensory Medical's Relaxis system.

Food & Drug Administration (FDA), Sensory Medical

News Well, Regulatory/Clearance, 510(k), Food & Drug Administration (FDA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1koDDL5